nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Papule—Hydroxyurea—head and neck cancer	0.0634	0.0802	CcSEcCtD
Fluocinolone Acetonide—Skin atrophy—Hydroxyurea—head and neck cancer	0.0459	0.058	CcSEcCtD
Fluocinolone Acetonide—Telangiectasia—Fluorouracil—head and neck cancer	0.0423	0.0535	CcSEcCtD
Fluocinolone Acetonide—Common cold—Fluorouracil—head and neck cancer	0.0382	0.0483	CcSEcCtD
Fluocinolone Acetonide—Allergic contact dermatitis—Fluorouracil—head and neck cancer	0.0285	0.0361	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—phospho-PLA2 pathway—MAPK1—head and neck cancer	0.0233	0.119	CbGpPWpGaD
Fluocinolone Acetonide—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.0233	0.0294	CcSEcCtD
Fluocinolone Acetonide—Skin irritation—Fluorouracil—head and neck cancer	0.023	0.0291	CcSEcCtD
Fluocinolone Acetonide—Photopsia—Docetaxel—head and neck cancer	0.0226	0.0286	CcSEcCtD
Fluocinolone Acetonide—Blepharitis—Hydroxyurea—head and neck cancer	0.0225	0.0285	CcSEcCtD
Fluocinolone Acetonide—Lacrimation—Fluorouracil—head and neck cancer	0.0169	0.0214	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.0168	0.0212	CcSEcCtD
Fluocinolone Acetonide—Blepharitis—Fluorouracil—head and neck cancer	0.0162	0.0205	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.0144	0.0737	CbGpPWpGaD
Fluocinolone Acetonide—Photophobia—Vinblastine—head and neck cancer	0.0143	0.018	CcSEcCtD
Fluocinolone Acetonide—Lacrimation—Docetaxel—head and neck cancer	0.0122	0.0155	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.0121	0.0153	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Fluorouracil—head and neck cancer	0.0117	0.0148	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Fluorouracil—head and neck cancer	0.0108	0.0137	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Fluorouracil—head and neck cancer	0.0108	0.0137	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Fluorouracil—head and neck cancer	0.00985	0.0125	CcSEcCtD
Fluocinolone Acetonide—Photophobia—Fluorouracil—head and neck cancer	0.00936	0.0118	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Docetaxel—head and neck cancer	0.00924	0.0117	CcSEcCtD
Fluocinolone Acetonide—Rhinorrhoea—Docetaxel—head and neck cancer	0.00888	0.0112	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Docetaxel—head and neck cancer	0.00842	0.0107	CcSEcCtD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00829	0.0424	CbGpPWpGaD
Fluocinolone Acetonide—Lacrimation increased—Docetaxel—head and neck cancer	0.00781	0.00987	CcSEcCtD
Fluocinolone Acetonide—Infestation—Hydroxyurea—head and neck cancer	0.00775	0.00979	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Hydroxyurea—head and neck cancer	0.00775	0.00979	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—RARB—head and neck cancer	0.00725	0.037	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00714	0.0365	CbGpPWpGaD
Fluocinolone Acetonide—Alopecia—Vinblastine—head and neck cancer	0.00674	0.00852	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00647	0.00818	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Hydroxyurea—head and neck cancer	0.00614	0.00777	CcSEcCtD
Fluocinolone Acetonide—Erythema—Hydroxyurea—head and neck cancer	0.00605	0.00765	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Vinblastine—head and neck cancer	0.00596	0.00754	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00581	0.00735	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00573	0.0293	CbGpPWpGaD
Fluocinolone Acetonide—Infestation NOS—Fluorouracil—head and neck cancer	0.00558	0.00705	CcSEcCtD
Fluocinolone Acetonide—Infestation—Fluorouracil—head and neck cancer	0.00558	0.00705	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Docetaxel—head and neck cancer	0.00551	0.00697	CcSEcCtD
Fluocinolone Acetonide—Clobetasol propionate—CYP1A1—head and neck cancer	0.00531	0.4	CrCbGaD
Fluocinolone Acetonide—Sinusitis—Fluorouracil—head and neck cancer	0.00523	0.00661	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Docetaxel—head and neck cancer	0.00522	0.0066	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Fluorouracil—head and neck cancer	0.00502	0.00634	CcSEcCtD
Fluocinolone Acetonide—Oedema—Hydroxyurea—head and neck cancer	0.00494	0.00625	CcSEcCtD
Fluocinolone Acetonide—Infection—Hydroxyurea—head and neck cancer	0.00491	0.0062	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00484	0.00612	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Docetaxel—head and neck cancer	0.00467	0.0059	CcSEcCtD
Fluocinolone Acetonide—Pain—Vinblastine—head and neck cancer	0.00463	0.00586	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Fluorouracil—head and neck cancer	0.00442	0.00559	CcSEcCtD
Fluocinolone Acetonide—Erythema—Fluorouracil—head and neck cancer	0.00436	0.00551	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00426	0.00539	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00425	0.0217	CbGpPWpGaD
Fluocinolone Acetonide—Pain—Hydroxyurea—head and neck cancer	0.00422	0.00534	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00421	0.0215	CbGpPWpGaD
Fluocinolone Acetonide—Vision blurred—Fluorouracil—head and neck cancer	0.00411	0.00519	CcSEcCtD
Fluocinolone Acetonide—Infestation—Docetaxel—head and neck cancer	0.00402	0.00509	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Docetaxel—head and neck cancer	0.00402	0.00509	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vinblastine—head and neck cancer	0.00399	0.00505	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00391	0.00494	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.00377	0.0193	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Vinblastine—head and neck cancer	0.00371	0.00469	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00364	0.0046	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Docetaxel—head and neck cancer	0.00362	0.00458	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vinblastine—head and neck cancer	0.00358	0.00453	CcSEcCtD
Fluocinolone Acetonide—Oedema—Fluorouracil—head and neck cancer	0.00356	0.0045	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Docetaxel—head and neck cancer	0.00355	0.00449	CcSEcCtD
Fluocinolone Acetonide—Infection—Fluorouracil—head and neck cancer	0.00353	0.00447	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Fluorouracil—head and neck cancer	0.00349	0.00441	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.00349	0.0178	CbGpPWpGaD
Fluocinolone Acetonide—Visual impairment—Docetaxel—head and neck cancer	0.00348	0.0044	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vinblastine—head and neck cancer	0.00344	0.00435	CcSEcCtD
Fluocinolone Acetonide—Headache—Vinblastine—head and neck cancer	0.00339	0.00429	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00338	0.00427	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Docetaxel—head and neck cancer	0.00338	0.00427	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.00333	0.017	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Hydroxyurea—head and neck cancer	0.00327	0.00413	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Docetaxel—head and neck cancer	0.00326	0.00412	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00324	0.0041	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vinblastine—head and neck cancer	0.00322	0.00407	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Docetaxel—head and neck cancer	0.00319	0.00404	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Docetaxel—head and neck cancer	0.00316	0.004	CcSEcCtD
Fluocinolone Acetonide—Erythema—Docetaxel—head and neck cancer	0.00314	0.00398	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Docetaxel—head and neck cancer	0.00314	0.00398	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Hydroxyurea—head and neck cancer	0.00314	0.00397	CcSEcCtD
Fluocinolone Acetonide—Rash—Hydroxyurea—head and neck cancer	0.00311	0.00394	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Hydroxyurea—head and neck cancer	0.00311	0.00393	CcSEcCtD
Fluocinolone Acetonide—Headache—Hydroxyurea—head and neck cancer	0.00309	0.00391	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Docetaxel—head and neck cancer	0.00308	0.00389	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00307	0.00388	CcSEcCtD
Fluocinolone Acetonide—Back pain—Docetaxel—head and neck cancer	0.00304	0.00385	CcSEcCtD
Fluocinolone Acetonide—Pain—Fluorouracil—head and neck cancer	0.00304	0.00384	CcSEcCtD
Fluocinolone Acetonide—Nausea—Hydroxyurea—head and neck cancer	0.00293	0.00371	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.00286	0.0146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00282	0.0144	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Fluorouracil—head and neck cancer	0.00281	0.00355	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.00279	0.0142	CbGpPWpGaD
Fluocinolone Acetonide—Cough—Docetaxel—head and neck cancer	0.00274	0.00347	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.00272	0.0139	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Docetaxel—head and neck cancer	0.00268	0.00338	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Ca-dependent events—MAPK1—head and neck cancer	0.00267	0.0137	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Fluorouracil—head and neck cancer	0.00262	0.00331	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—PTGS2—head and neck cancer	0.00261	0.196	CrCbGaD
Fluocinolone Acetonide—Oedema—Docetaxel—head and neck cancer	0.00257	0.00324	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00256	0.0131	CbGpPWpGaD
Fluocinolone Acetonide—Infection—Docetaxel—head and neck cancer	0.00255	0.00322	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Docetaxel—head and neck cancer	0.00252	0.00318	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Fluorouracil—head and neck cancer	0.00252	0.00318	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.0025	0.0128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—CASP8—head and neck cancer	0.00246	0.0126	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Fluorouracil—head and neck cancer	0.00243	0.00308	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—STAT3—head and neck cancer	0.00238	0.0122	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Fluorouracil—head and neck cancer	0.00235	0.00297	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00234	0.00296	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—MAPK3—head and neck cancer	0.00228	0.0116	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Fluorouracil—head and neck cancer	0.00226	0.00286	CcSEcCtD
Fluocinolone Acetonide—Rash—Fluorouracil—head and neck cancer	0.00224	0.00283	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Fluorouracil—head and neck cancer	0.00224	0.00283	CcSEcCtD
Fluocinolone Acetonide—Headache—Fluorouracil—head and neck cancer	0.00223	0.00282	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00222	0.0028	CcSEcCtD
Fluocinolone Acetonide—Pain—Docetaxel—head and neck cancer	0.00219	0.00277	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—MAPK1—head and neck cancer	0.00217	0.0111	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—head and neck cancer	0.00214	0.161	CrCbGaD
Fluocinolone Acetonide—Nausea—Fluorouracil—head and neck cancer	0.00211	0.00267	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Docetaxel—head and neck cancer	0.00203	0.00257	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP1A1—head and neck cancer	0.00199	0.15	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.00198	0.0101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PLC beta mediated events—MAPK1—head and neck cancer	0.00197	0.01	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—head and neck cancer	0.00194	0.00992	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—G-protein mediated events—MAPK1—head and neck cancer	0.00193	0.00987	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Docetaxel—head and neck cancer	0.00189	0.00239	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.00187	0.00953	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Docetaxel—head and neck cancer	0.00182	0.0023	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Docetaxel—head and neck cancer	0.00176	0.00222	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—HRAS—head and neck cancer	0.00174	0.00888	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Docetaxel—head and neck cancer	0.0017	0.00215	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Docetaxel—head and neck cancer	0.00163	0.00206	CcSEcCtD
Fluocinolone Acetonide—Rash—Docetaxel—head and neck cancer	0.00162	0.00205	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Docetaxel—head and neck cancer	0.00162	0.00204	CcSEcCtD
Fluocinolone Acetonide—Headache—Docetaxel—head and neck cancer	0.00161	0.00203	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK3—head and neck cancer	0.00159	0.00813	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—STAT3—head and neck cancer	0.00156	0.00799	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—MAPK3—head and neck cancer	0.00155	0.00792	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00154	0.00786	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Docetaxel—head and neck cancer	0.00152	0.00193	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK1—head and neck cancer	0.00151	0.00774	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MAPK3—head and neck cancer	0.00149	0.00764	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—MAPK1—head and neck cancer	0.00148	0.00754	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MAPK1—head and neck cancer	0.00142	0.00726	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—EGFR—head and neck cancer	0.00142	0.00726	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—UROD—head and neck cancer	0.00138	0.00704	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—head and neck cancer	0.00131	0.00671	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.00126	0.00641	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—head and neck cancer	0.00124	0.0935	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.00122	0.00625	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—head and neck cancer	0.00122	0.00621	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—MAPK1—head and neck cancer	0.00121	0.00617	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—HRAS—head and neck cancer	0.00119	0.00605	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.00118	0.00603	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.00111	0.00565	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—head and neck cancer	0.00107	0.00548	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00107	0.00546	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00105	0.00537	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PTEN—head and neck cancer	0.00105	0.00536	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—head and neck cancer	0.00105	0.00535	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—head and neck cancer	0.00101	0.00515	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.00099	0.00506	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000987	0.00504	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PTEN—head and neck cancer	0.00097	0.00495	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—KISS1—head and neck cancer	0.000953	0.00487	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—STAT3—head and neck cancer	0.000939	0.00479	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000902	0.00461	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.0009	0.0046	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK3—head and neck cancer	0.000897	0.00458	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000889	0.00454	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000857	0.00438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—head and neck cancer	0.000853	0.00436	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000846	0.00432	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000806	0.00412	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRP—head and neck cancer	0.000785	0.00401	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000775	0.00396	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000748	0.00382	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—head and neck cancer	0.00074	0.00378	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.00071	0.00363	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000707	0.00361	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—HRAS—head and neck cancer	0.000685	0.0035	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PIK3CA—head and neck cancer	0.000684	0.00349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000675	0.00345	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.000644	0.00329	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000639	0.00326	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000608	0.00311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000608	0.0031	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000608	0.0031	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000606	0.00309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000602	0.00307	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000601	0.00307	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.0006	0.00306	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NAT2—head and neck cancer	0.000573	0.00292	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000568	0.0029	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KISS1—head and neck cancer	0.000563	0.00288	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000562	0.00287	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000541	0.00276	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000527	0.00269	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.00051	0.00261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DPYD—head and neck cancer	0.000502	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RARB—head and neck cancer	0.000477	0.00243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—YAP1—head and neck cancer	0.000476	0.00243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000469	0.0024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRP—head and neck cancer	0.000464	0.00237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT6—head and neck cancer	0.00045	0.0023	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000434	0.00221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000431	0.0022	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000406	0.00207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—YAP1—head and neck cancer	0.000398	0.00203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000383	0.00196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IL2—head and neck cancer	0.000364	0.00186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000358	0.00183	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000312	0.00159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—head and neck cancer	0.00031	0.00158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK3—head and neck cancer	0.000293	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TYMS—head and neck cancer	0.000286	0.00146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GSTM1—head and neck cancer	0.000283	0.00144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—MAPK1—head and neck cancer	0.000279	0.00142	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPX1—head and neck cancer	0.000271	0.00138	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP1A1—head and neck cancer	0.000268	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PIK3CA—head and neck cancer	0.000242	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—head and neck cancer	0.000234	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—head and neck cancer	0.000224	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.00022	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL2—head and neck cancer	0.000209	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—head and neck cancer	0.000198	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH1—head and neck cancer	0.000195	0.000998	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH1—head and neck cancer	0.00018	0.000917	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK3—head and neck cancer	0.000168	0.000859	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MAPK1—head and neck cancer	0.00016	0.000817	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—EGFR—head and neck cancer	0.00016	0.000817	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—head and neck cancer	0.000159	0.000814	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTEN—head and neck cancer	0.000139	0.00071	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PIK3CA—head and neck cancer	0.000139	0.000709	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—head and neck cancer	0.000128	0.000656	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL2—head and neck cancer	0.000124	0.000631	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—head and neck cancer	0.00012	0.000615	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTEN—head and neck cancer	0.000116	0.000594	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—head and neck cancer	0.000113	0.000579	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAPK3—head and neck cancer	0.000108	0.000552	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—head and neck cancer	0.000105	0.000536	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—STAT3—head and neck cancer	0.000104	0.000531	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK3—head and neck cancer	9.93e-05	0.000507	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PIK3CA—head and neck cancer	9.81e-05	0.000501	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK1—head and neck cancer	9.45e-05	0.000483	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EGFR—head and neck cancer	9.45e-05	0.000483	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PIK3CA—head and neck cancer	8.2e-05	0.000419	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—head and neck cancer	8.01e-05	0.000409	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—head and neck cancer	7.93e-05	0.000405	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—head and neck cancer	7.59e-05	0.000388	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—head and neck cancer	7.29e-05	0.000372	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—head and neck cancer	6.7e-05	0.000342	CbGpPWpGaD
